Soluble expression, purification, and characterization of recombinant human flotillin-2 (reggie-1) in Escherichia coli

被引:0
|
作者
Jiaping Song
Wentao Chen
Zhisheng Lu
Xiaojian Hu
Yu Ding
机构
[1] Fudan University,Department of Physiology and Biophysics, School of Life Sciences
来源
Molecular Biology Reports | 2011年 / 38卷
关键词
Flotillin-2 (reggie 1); Flotillin-1 (reggie 2); MBP tag; Lipid rafts;
D O I
暂无
中图分类号
学科分类号
摘要
Large scale production of recombinant human flotillin-2 (reggie-1) is desirable for structural and biochemical studies. However, as the major lipid rafts specific hydrophobic protein, flotillin-2 was difficult to be expressed as soluble and functional form in prokaryotic system. In this study, we first cloned and expressed human flotillin-2 in Escherichia coli with five different fusion tags: poly-histidine, glutathione S-transferase (GST), thioredoxin (TRX), N-Utilization substance (NusA) and maltose binding protein (MBP). We screened the expression level and solubility of the five flotillin-2 fusion proteins, the best MBP tagged flotillin-2 was then large scale produced. The optimized purification procedure included two steps of chromatography: Ni-NTA affinity chromatography and anion exchange chromatography. The typical yield was 36.0 mg soluble and functional recombinant flotillin-2 from 1 L of culture medium with purity above 97%. The activity of recombinant flotillin-2 was verified by pull-down assay with flotillin-1, showing that the purified recombinant flotillin-2 can specifically interact with flotillin-1. The circular dichroism (CD) spectroscopy showed that recombinant flotillin-2 had a very stable secondary structure dominated by α-helix, β-turn and random structure.
引用
收藏
页码:2091 / 2098
页数:7
相关论文
共 50 条
  • [41] RECOMBINANT SOLUBLE HUMAN INTERLEUKIN-6 RECEPTOR - EXPRESSION IN ESCHERICHIA-COLI, RENATURATION AND PURIFICATION
    STOYAN, T
    MICHAELIS, U
    SCHOOLTINK, H
    VANDAM, M
    RUDOLPH, R
    HEINRICH, PC
    ROSEJOHN, S
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 216 (01): : 239 - 245
  • [42] Recombinant expression, purification, and characterization of full-length human BST-2 from Escherichia coli
    Marivate, Amukelani
    Njengele-Tetyana, Zikhona
    Fish, Muhammad Qasim
    Mosebi, Salerwe
    PROTEIN EXPRESSION AND PURIFICATION, 2021, 188
  • [43] Recombinant expression, purification and characterization of antimicrobial peptide ORBK in Escherichia coli
    Li, Yan
    Wang, Jiarong
    Yang, Jing
    Wan, Chanjuan
    Wang, Xiaoming
    Sun, Hongbin
    PROTEIN EXPRESSION AND PURIFICATION, 2014, 95 : 182 - 187
  • [44] Expression and purification of recombinant human CUL2 from Escherichia coli cells
    Diaz, Stephanie
    Li, Lihong
    Wang, Kankan
    Liu, Xing
    FASEB JOURNAL, 2021, 35
  • [45] PURIFICATION AND CHARACTERIZATION OF RECOMBINANT HUMAN INTERLEUKIN-2 PRODUCED IN ESCHERICHIA-COLI
    KATO, K
    YAMADA, T
    KAWAHARA, K
    ONDA, H
    ASANO, T
    SUGINO, H
    KAKINUMA, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (02) : 692 - 699
  • [46] Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli
    Yi-Qin Luo
    Liang-Hua Wang
    Qui Yi
    Bing-Hua Jiao
    Clinical and Experimental Medicine, 2008, 8 : 37 - 42
  • [47] Expression and Purification of Recombinant Hemoglobin in Escherichia coli
    Natarajan, Chandrasekhar
    Jiang, Xiaoben
    Fago, Angela
    Weber, Roy E.
    Moriyama, Hideaki
    Storz, Jay F.
    PLOS ONE, 2011, 6 (05):
  • [48] Expression of soluble, biologically active recombinant human endostatin in Escherichia coli
    Xu, HM
    Zhang, GY
    Ji, XD
    Cao, L
    Shu, L
    Hua, ZC
    PROTEIN EXPRESSION AND PURIFICATION, 2005, 41 (02) : 252 - 258
  • [49] Expression of soluble, biologically active recombinant human tumstatin in Escherichia coli
    Luo, Yi-Qin
    Wang, Liang-Hua
    Yi, Qui
    Jiao, Bing-Hua
    CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 8 (01) : 37 - 42
  • [50] Expression and purification of recombinant lysostaphin in Escherichia coli
    Chan, EC
    BIOTECHNOLOGY LETTERS, 1996, 18 (07) : 833 - 838